Outcomes of sorafenib treatment of advanced renal cell carcinoma according to IMDC risk criteria: analysis of Japanese real-world data from postmarketing all-patient surveillance of sorafenib

Teruo Inamoto, Haruhito Azuma, Masatoshi Adachi, Yutaka Okayama, Toshiyuki Sunaya, Mototsugu Oya

研究成果: Article査読

フィンガープリント

「Outcomes of sorafenib treatment of advanced renal cell carcinoma according to IMDC risk criteria: analysis of Japanese real-world data from postmarketing all-patient surveillance of sorafenib」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences